These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 20570567)
1. Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide. Bontkes HJ; Moreno M; Hangalapura B; Lindenberg JJ; de Groot J; Lougheed S; van der Vliet HJ; van den Eertwegh AJ; de Gruijl TD; von Blomberg BM; Scheper RJ Clin Immunol; 2010 Sep; 136(3):364-74. PubMed ID: 20570567 [TBL] [Abstract][Full Text] [Related]
2. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes. Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368 [TBL] [Abstract][Full Text] [Related]
3. Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells. Tripp CH; Sparber F; Hermans IF; Romani N; Stoitzner P J Immunol; 2009 Jun; 182(12):7644-54. PubMed ID: 19494288 [TBL] [Abstract][Full Text] [Related]
4. Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation. Iyoda T; Ushida M; Kimura Y; Minamino K; Hayuka A; Yokohata S; Ehara H; Inaba K Int Immunol; 2010 Nov; 22(11):905-13. PubMed ID: 21118907 [TBL] [Abstract][Full Text] [Related]
5. Sulfatide inhibits α-galactosylceramide presentation by dendritic cells. Kanamori M; Tasumi Y; Iyoda T; Ushida M; Inaba K Int Immunol; 2012 Feb; 24(2):129-36. PubMed ID: 22247226 [TBL] [Abstract][Full Text] [Related]
6. Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer. Ko SY; Lee KA; Youn HJ; Kim YJ; Ko HJ; Heo TH; Kweon MN; Kang CY Eur J Immunol; 2007 Aug; 37(8):2127-37. PubMed ID: 17615581 [TBL] [Abstract][Full Text] [Related]
7. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles. Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695 [TBL] [Abstract][Full Text] [Related]
8. Activation or anergy: NKT cells are stunned by alpha-galactosylceramide. Sullivan BA; Kronenberg M J Clin Invest; 2005 Sep; 115(9):2328-9. PubMed ID: 16138189 [TBL] [Abstract][Full Text] [Related]
9. Role of marginal zone B lymphocytes in invariant NKT cell activation. Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762 [TBL] [Abstract][Full Text] [Related]
10. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities. Wu L; Gabriel CL; Parekh VV; Van Kaer L Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798 [TBL] [Abstract][Full Text] [Related]
11. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model. Kim JO; Kim DH; Chang WS; Hong C; Park SH; Kim S; Kang CY J Allergy Clin Immunol; 2004 Dec; 114(6):1332-8. PubMed ID: 15577831 [TBL] [Abstract][Full Text] [Related]
12. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913 [TBL] [Abstract][Full Text] [Related]
13. NKT cell ligand alpha-galactosylceramide blocks the induction of oral tolerance by triggering dendritic cell maturation. Chung Y; Chang WS; Kim S; Kang CY Eur J Immunol; 2004 Sep; 34(9):2471-9. PubMed ID: 15307179 [TBL] [Abstract][Full Text] [Related]
14. Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice. Homma T; Kinugawa S; Takahashi M; Sobirin MA; Saito A; Fukushima A; Suga T; Takada S; Kadoguchi T; Masaki Y; Furihata T; Taniguchi M; Nakayama T; Ishimori N; Iwabuchi K; Tsutsui H J Mol Cell Cardiol; 2013 Sep; 62():179-88. PubMed ID: 23774048 [TBL] [Abstract][Full Text] [Related]
15. Activated NKT cells increase dendritic cell migration and enhance CD8+ T cell responses in the skin. Gorbachev AV; Fairchild RL Eur J Immunol; 2006 Sep; 36(9):2494-503. PubMed ID: 16909435 [TBL] [Abstract][Full Text] [Related]
16. Effective stimulation of invariant natural killer T cells by oligomannose-coated liposomes. Ishii M; Kojima N Int Immunopharmacol; 2013 Apr; 15(4):685-92. PubMed ID: 23535021 [TBL] [Abstract][Full Text] [Related]
17. Functional maturation of lamina propria dendritic cells by activation of NKT cells mediates the abrogation of oral tolerance. Chang JH; Lee JM; Youn HJ; Lee KA; Chung Y; Lee AY; Kweon MN; Kim HY; Taniguchi M; Kang CY Eur J Immunol; 2008 Oct; 38(10):2727-39. PubMed ID: 18825753 [TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells. Gaffal E; Schweichel D; Tormo D; Steitz J; Lenz J; Basner-Tschakarjan E; Limmer A; Tüting T Eur J Cell Biol; 2007 Dec; 86(11-12):817-26. PubMed ID: 16928407 [TBL] [Abstract][Full Text] [Related]
19. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells. Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431 [TBL] [Abstract][Full Text] [Related]
20. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells. Kim HY; Pichavant M; Matangkasombut P; Koh YI; Savage PB; DeKruyff RH; Umetsu DT J Immunol; 2009 Mar; 182(5):3252-61. PubMed ID: 19234223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]